Citation

Karakaya I, Basar K, Aki OE, Ozer S. Dusunen Adam J. Psychiatry Neurol. Sci. 2018; 31(3): 308-311.

Copyright

(Copyright © 2018, Yerkure Tanitim ve Yayincilik Hizmetleri)

DOI

10.5350/DAJPN2018310310

PMID

unavailable

Abstract

Electroconvulsive therapy (ECT) is a comparably safe treatment option frequently administered for treatment-refractory mental disorders. It has no absolute contraindication; however, careful attention should be given when ECT is applied to patients with comorbid conditions. Intracranial aneurysms are among the comorbidities that increase certain risks associated with ECT. Increase in cerebral blood flow during ECT may be associated with increased risk of rupture of an aneurysm and bleeding from vascular malformation. In the literature, there is a limited number of case reports on ECT administration in patients with surgically repaired cerebral aneurysm. In this case report, application of ECT in a 53-year-old female patient diagnosed with treatment-refractory major depressive disorder and with a history of surgical repair for intracranial aneurysm is presented. In addition, special considerations and precautions about ECT application for patients with repaired intracranial aneurysms are reviewed. © 2018 Yerkure Tanitim ve Yayincilik Hizmetleri A.S..All right reserved.

Language: en

Keywords

adult; human; Depression; female; case report; depression; suicide attempt; major depression; lithium; hospitalization; Electroconvulsive therapy; wellbeing; risk factor; epilepsy; mental disease; antidepressant agent; clinical article; fluoxetine; mirtazapine; paroxetine; sertraline; venlafaxine; automutilation; headache; quetiapine; middle aged; necrosis; electroconvulsive therapy; paracetamol; social status; seizure; neurosurgery; follow up; heart injury; tianeptine; drug withdrawal; glyceryl trinitrate; hypertension; recurrence risk; lamotrigine; heart rate; electrocardiogram; midazolam; modafinil; Beck Depression Inventory; suxamethonium; thorax pain; blood pressure; furosemide; drug dose reduction; Article; thiopental; doxazosin; systolic blood pressure; biological marker; drug dose increase; encephalomalacia; agomelatine; esmolol; carvedilol; premedication; functional neuroimaging; aneurysm rupture; middle cerebral artery; levetiracetam; Hamilton Depression Rating Scale; hydrochlorothiazide plus irbesartan; Intracranial aneurism; intracranial aneurysm; speech rate